The number of drug overdose deaths in the United States dropped again last year, marking the third straight annual decline after years of devastating losses during the COVID-19 pandemic. According to new preliminary federal data, around 70,000 Americans died from overdoses in 2025, a significant decrease from previous years.
While health experts say the decline is encouraging, many also warn that the overdose crisis is far from over. Researchers and public health officials say changes in drug supplies, government policies, and emerging substances could still reverse the progress seen over the past few years.
Overdose Deaths Continue To Decline in the U.S.
According to preliminary data released by the Centers for Disease Control and Prevention, overdose deaths in the United States dropped by approximately 14% compared to the previous year.
The 2025 death total of roughly 70,000 is now close to the number recorded in 2019 before the COVID-19 pandemic dramatically worsened the overdose crisis.
Health experts say this is the longest continuous decline in overdose deaths seen in decades.
The decrease was reported across several major drug categories, including fentanyl, cocaine, and methamphetamine.
Most states experienced declines in overdose deaths, although a few states, including Arizona, Colorado, and New Mexico, saw increases.
Researchers believe the rise in those states may be connected to the growing combined use of fentanyl and methamphetamine.
Pandemic Years Caused Sharp Increase in Overdose Deaths
The United States had already been facing a growing overdose epidemic for many years before the pandemic began.
However, overdose deaths surged dramatically during the height of COVID-19, eventually reaching nearly 110,000 deaths in 2022.
Experts say social isolation, mental health struggles, and limited access to addiction treatment services contributed heavily to the spike during the pandemic years.
As pandemic conditions eased, overdose deaths gradually began declining again.
Researchers believe several factors may have helped reduce deaths in recent years.
Experts Point To Several Reasons for Improvement
Health specialists say wider availability of naloxone, the medication used to reverse overdoses, likely played an important role in reducing deaths.
Expanded addiction treatment programs and billions of dollars from opioid lawsuit settlements may have also helped improve access to support services.
Some researchers believe fewer young people are beginning to use drugs, while many longtime users have already died from overdoses over the years.
Other experts point to international changes affecting fentanyl production.
Regulatory actions in China targeting chemicals used to manufacture fentanyl may have reduced some of the drug supply entering the United States.
Still, researchers warn that the illegal drug market continues changing rapidly.
New Dangerous Drugs Entering the Drug Supply
According to experts monitoring illegal substances, new synthetic drugs are appearing at an alarming pace.
Alex Krotulski said his laboratory identified 27 new drugs throughout all of last year.
Less than five months into 2026, the same lab has already detected 23 additional new substances.
Among the growing concerns is cychlorphine, a synthetic opioid reportedly up to 10 times stronger than fentanyl.
Experts say these substances are sometimes secretly mixed into other drugs without users knowing.
Veterinary sedatives such as xylazine and medetomidine are also increasingly appearing in the drug supply.
Although they may not always directly cause overdoses like fentanyl, these substances can severely slow breathing, cause blackouts, and create dangerous wounds or infections.
Concerns Grow Over Federal Funding Cuts
Some public health advocates worry recent federal policy changes could weaken overdose prevention efforts.
The Substance Abuse and Mental Health Services Administration recently informed grant recipients that federal funding would no longer cover fentanyl and xylazine test strips.
These test strips help drug users detect deadly substances hidden inside illegal drugs.
Shreeta Waldon said her organisation lost a major federal grant that had helped distribute tens of thousands of fentanyl test strips.
Advocates argue that removing harm reduction tools could increase overdose risks and reverse recent progress.
At the same time, the Trump administration has defended shifting away from programs it believes encourage illegal drug use, including clean syringe programs and overdose hotline services.
White House Expanding New Drug Monitoring Strategies
The White House recently released a large anti-drug strategy plan focused on using technology and surveillance to monitor illegal drug activity.
The plan reportedly includes wastewater testing to measure drug use trends and artificial intelligence systems designed to identify smuggled substances and predict overdose risks.
Supporters believe these tools could help law enforcement and health officials respond more quickly to emerging drug threats.
However, critics warn that treatment access and harm reduction programs remain essential parts of addressing the crisis.
Drug policy advocates continue stressing that overdose deaths may rise again if prevention and treatment programs lose support.
Although overdose deaths have finally begun declining after years of devastating losses, experts warn that the crisis remains extremely serious in the United States. The appearance of increasingly powerful synthetic drugs and changes to harm reduction programs continue raising concerns among public health researchers.
While many communities have made progress through expanded treatment, naloxone access, and prevention efforts, experts say maintaining those gains will require continued attention, funding, and support. The coming years may determine whether the recent decline becomes a lasting trend or only a temporary improvement in America’s long-running overdose epidemic.
